Skip to content
Noa Therapeutics Logo

About us

Noa Therapeutics is a preclinical biotech company leveraging a systems biology approach to accelerate design of tailored multimodal therapeutics for complex inflammatory diseases. With discrete expertise in dermal therapeutics, Noa is advancing a first-use case in Atopic Dermatitis. Noa’s lead ID, NOA-101, simultaneously addresses three constructive targets to address persistent unmet needs to displace multiple major players within the $5.0B, 10.1% CAGR, US Market; paving the way for pipeline expansion into >$70B inflammatory disease markets.

Program engagement

Leadership

Carla Spina

CEO & Co-Founder

Serena Mandla

CSO & Co-Founder

Status

Intellectual Property

Fundraising

Sector

Subsector

Whether you are looking for support in product development, validation or just networking, our role is to help make services more visible to you and to reduce the amount of time it takes to activate these supports.

Ready to accelerate your business growth?

Founders Fast Track is 6 week mentorship program that provides your startup with access to industry expertise, resources, networking opportunities, and skills to help you secure investment capital.

Applications are open until April 13, 2025. 

Synapse Life Science Pitch Competition March 26, 2025 from 4:00pm - 8:00pm EDT

Get tickets for the 2025 Synapse Competition!

Innovation Factory’s Synapse Competition is Ontario’s premier life science pitch competition, dedicated to fostering innovation in the life science sector.

Why you should attend:

  • Meet the finalists at the 12th annual Synapse Competition showcase!
  • Discover emerging life science innovations
  • Network with industry leaders and Ontario’s thriving life science ecosystem.

March 26, 2025 | 4:00pm – 8:00pm EDT